Find News

Filter articles

Showing 101 to 110 of 3079 results

Sandoz fails in Enbrel patent challenge, but Fed Circuit split

US02-07-2020Rory O'Neill

Amgen has won a key patent victory over Sandoz in a dispute over biologic Enbrel.

Glenmark becomes fifth generic to be charged with US antitrust violations

02-07-2020Muireann Bolger

Glenmark Pharmaceuticals has been charged with conspiring to fix prices for generic drugs, according to a statement released by the US Department of Justice.

Chiesi blocks Japanese drugmaker’s new brand at EU General Court


Japan-based Nitto Pharmaceutical Industries has been blocked from using its ‘Noster’ brand in the EU, in a win for Italian drugmaker Chiesi Farmaceutici.

Labrador drops BioFire suit after COVID-19 revelation


Labrador Diagnostics has dropped its controversial patent complaint against COVID-19 test developer BioMerieux.

J&J wants $25m over ‘contaminated’ fake medical tools


Johnson & Johnson has accused a medical supplier of distributing counterfeit surgical tools that are “bacterially contaminated and critically defective”.

LSPN Connect: MPP chief wants COVID-19 role

26-06-2020Rory O'Neill

The executive director of the Medicines Patent Pool says it should have a role in fighting COVID-19, but it’s up to stakeholders to agree what that will be.

English appeals court refuses Neurim injunction for insomnia drug


The English Court of Appeal has rejected Neurim’s attempt to block sales of a generic version of its insomnia drug made by Mylan ahead of a patent infringement trial. 

Latham recruits two from Hogan Lovells


Latham & Watkins has added two life sciences-focused litigators, Arlene Chow and Ernest Yakob, to its New York office.

Gilead expands oncology business with Pionyr deal

US25-06-2020Mergers & acquisitions

Gilead Sciences has begun a potential takeover of Pionyr Immunotherapeutics after it agreed to pay $275 million for a 49.9% equity stake in the cancer research company.

Kymab victorious before UK Supreme Court in Regeneron appeal

UK24-06-2020Sarah Morgan

The UK Supreme Court today has sided with biopharmaceutical company Kymab, allowing its appeal in a suit involving Regeneron and patents covering transgenic mice. 

Showing 101 to 110 of 3079 results